Asahi Life Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,310
Closed -$430K 184
2024
Q3
$430K Buy
+6,310
New +$356K 0.26% 89
2024
Q2
Sell
-5,650
Closed -$390K 177
2024
Q1
$390K Buy
5,650
+1,260
+29% +$79.7K 0.23% 97
2023
Q4
$325K Buy
4,390
+175
+4% +$11.5K 0.18% 130
2023
Q3
$288K Buy
4,215
+785
+23% +$66.6K 0.1% 132
2023
Q2
$322K Sell
3,430
-1,060
-24% -$82.7K 0.11% 124
2023
Q1
$304K Buy
+4,490
New +$289K 0.1% 133
2020
Q4
Sell
-2,140
Closed -$218K 222
2020
Q3
$218K Sell
2,140
-380
-15% -$32.8K 0.03% 166
2020
Q2
$219K Buy
+2,520
New +$201K 0.04% 153
2020
Q1
Sell
-4,590
Closed -$424K 209
2019
Q4
$424K Buy
+4,590
New +$404K 0.06% 123

Other funds holding EXAS

Asahi Life Asset Management's EXAS Position: Q4 2024 in Review

Asahi Life Asset Management sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 6,310 shares — an estimated $430K sold.

Asahi Life Asset Management first reported a position in EXAS in Q4 2019 and held it in 9 quarters. The position peaked at $430K in Q3 2024. 594 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Asahi Life Asset Management reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Asahi Life Asset Management sold 6,310 Exact Sciences shares in Q4 2024, an estimated $430K.
  • Asahi Life Asset Management first reported a position in Exact Sciences in Q4 2019 and held it in 9 quarters.
  • Asahi Life Asset Management's Exact Sciences position peaked at $430K in Q3 2024.
  • 594 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Asahi Life Asset Management's 13F filing for Q4 2024, filed 5 Feb 2025.